Vitamin K deficiency bleeding | |
---|---|
Other names | Haemorrhagic disease of the newborn |
Vitamin K1 | |
Specialty | Pediatrics |
Symptoms | Bleeding |
Usual onset | Birth to 2 months of age |
Types | Early, Classical, Late |
Causes | Vitamin K deficiency |
Prevention | Vitamin K supplementation after birth |
Vitamin K deficiency bleeding (VKDB) of the newborn, previously known as haemorrhagic disease of the newborn,[1] is a rare form of bleeding disorder that affects newborns and young infants due to low stores of vitamin K at birth.[2] It commonly presents with intracranial haemorrhage with the risk of brain damage or death.[3]
Newborn infants have low stores of vitamin K, and human breast milk has low concentrations of the vitamin. This combination can lead to vitamin K deficiency and later onset bleeding. Vitamin K deficiency leads to the risk of blood coagulation problems due to impaired production of clotting factors II, VII, IX, X, protein C and protein S by the liver. More rarely VKDB can be caused by maternal medicines causing vitamin K deficiency in the newborn.[2]
VKDB can largely be prevented by prophylactic supplementation of vitamin K, which is typically given shortly after birth by intramuscular injection. Most national health organisations recommend routine vitamin K supplementation after birth.[2] Widespread use of this has made this a rare disease.